Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | CHAT | P28329 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6320606 | 0.84 | TYR (0.38) | ALDH1A1CYP2A6 | |
| SCHEMBL27633315 | 0.80 | HTR2A (0.40) | HTR2AALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL8203826 | 0.78 | HTR2A (0.39) | HTR2AALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL3486113 | 0.78 | ALDH1A1 (0.43) | HTR2AALDH1A1TSHRMAOBLMNA | |
| SCHEMBL28740647 | 0.78 | ALDH1A1 (0.43) | HTR2AALDH1A1TSHRMAOBLMNA | |
| SCHEMBL8704500 | 0.78 | HTR2A (0.39) | HTR2AALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL3336700 | 0.78 | HTR2A (0.39) | HTR2AALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL9772815 | 0.78 | ALDH1A1 (0.43) | HTR2AALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL7572963 | 0.78 | HTR2A (0.48) | HTR2AALDH1A1CYP2A6LMNA | |
| SCHEMBL11046694 | 0.78 | HTR2A (0.39) | HTR2AALDH1A1TSHRMAOBCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116987263-A | Nylon, anti-dripping flame-retardant material containing nylon and preparation method | 中国科学院化学研究所 | 2023-11-03 | — | — | CN | claimed |
| WO-2023177249-A1 | NOVEL BINARY HISTONE DEACETYLASE INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 숙명여자대학교산학협력단 | 2023-09-21 | — | — | WO | claimed |
| WO-2023177250-A1 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 숙명여자대학교산학협력단 | 2023-09-21 | — | — | WO | claimed |
| CN-116355968-A | Method for synthesizing hydroxy cycloketene compounds by whole-cell catalysis | 兰州大学 | 2023-06-30 | — | — | CN | claimed |
| US-20230072538-A1 | METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE AND PATTERN FORMATION METHOD | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2023-03-09 | — | — | US | claimed |
| US-11041075-B2 | Self-healing composition, self-healing film, and device including the self-healing film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-06-22 | — | — | US | claimed |
| EP-3371148-B1 | USE AND PREPARATION OF REGULATORS FOR CONTROLLING LINEAR AND PSEUDO-RING EXPANSION POLYMERIZATION OF VINYL MONOMERS | DISPOLTEC B V (NL) | 2021-05-05 | — | — | EP | claimed |
| US-10947325-B2 | Regulators for controlling linear and pseudo-ring expansion polymerization of vinyl monomers | DISPOLTEC B.V. (NL) | 2021-03-16 | — | — | US | claimed |
| CN-111203105-A | Preparation method of multilayer reverse osmosis composite membrane | 厦门江天智能仿生科技有限公司 | 2020-05-29 | — | — | CN | claimed |
| EP-2951179-B1 | SPIRO-QUINAZOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS | MERCK PATENT GMBH (DE) | 2020-03-11 | — | — | EP | claimed |
| US-4692457-A | THIADIAZOLE CARBAMATES | FBC LIMITED (GB) | 1987-09-08 | — | — | US | claimed |
| US-4683234-A | HYPOTENSIVE AGENTS, ANTI-ANGINA | SUNTORY LIMITED (JP) | 1987-07-28 | — | — | US | claimed |
| EP-0228253-A1 | Rectally absorbable form of L-dopa | MERCK & CO. INC. (US) | 1987-07-08 | — | — | EP | claimed |
| US-4663349-A | Rectally absorbable form of L-dopa | MERCK & CO., INC. (US) | 1987-05-05 | — | — | US | claimed |
| CN-86102451-A | Formulate acaricidal method | — | 1986-11-26 | — | — | CN | claimed |
| EP-0200334-A2 | Acaricidal 1,2,4-thiadiazoles and their preparation | SCHERING AGROCHEMICALS LIMITED (GB) | 1986-11-05 | — | — | EP | claimed |
| US-4337352-A | SALT FORMATION WITH OPTICALLY ACTIVE AMINE | BAYER AKTIENGESELLSCHAFT (DE) | 1982-06-29 | — | — | US | claimed |
| US-4218469-A | Combating arthropods with 3-phenoxy-fluoro-benzyl carboxylic acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1980-08-19 | — | — | US | claimed |
| US-4199596-A | ESTERS, INSECTICIDES, MITICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-04-22 | — | — | US | claimed |
| US-4196151-A | Process for producing β,γ-unsaturated aldehyde | NIPPON OIL AND FATS CO., LTD. (JP) | 1980-04-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947325-B2 | Regulators for controlling linear and pseudo-ring expansion polymerization of vinyl monomers | ORC3, RPS27L, OXGR1 | HTR2A 4012/4885ALDH1A1 525/4885TSHR 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.